Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-2.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -13.12% |
| Q3 2025 | -44.29% |
| Q2 2025 | -25.87% |
| Q1 2025 | 11.97% |
| Q4 2024 | -18.76% |
| Q3 2024 | 6.13% |
| Q2 2024 | 22.83% |
| Q1 2024 | 10.40% |
| Q4 2023 | 2.61% |
| Q3 2023 | 1.38% |
| Q2 2023 | 13.07% |
| Q1 2023 | 17.25% |
| Q4 2022 | -2.21% |
| Q3 2022 | -6.57% |
| Q2 2022 | 26.12% |
| Q1 2022 | 11.35% |
| Q4 2021 | -10.93% |
| Q3 2021 | 9.54% |
| Q2 2021 | 3.73% |
| Q1 2021 | 3.77% |
| Q4 2020 | 5.75% |
| Q3 2020 | -3.72% |
| Q2 2020 | 25.99% |
| Q1 2020 | 18.69% |
| Q4 2019 | 8.79% |
| Q3 2019 | -17.70% |
| Q2 2019 | 11.48% |
| Q1 2019 | 0.00% |
| Q1 2018 | 0.00% |